DRUG
Price
$49.92
Change
-$0.18 (-0.36%)
Updated
Sep 24, 11:55 AM (EDT)
Capitalization
357.45M
WVE
Price
$6.75
Change
-$0.09 (-1.32%)
Updated
Sep 24, 12:37 PM (EDT)
Capitalization
1.09B
43 days until earnings call
Interact to see
Advertisement

DRUG vs WVE

Header iconDRUG vs WVE Comparison
Open Charts DRUG vs WVEBanner chart's image
Bright Minds Biosciences
Price$49.92
Change-$0.18 (-0.36%)
Volume$100
Capitalization357.45M
Wave Life Sciences
Price$6.75
Change-$0.09 (-1.32%)
Volume$650
Capitalization1.09B
DRUG vs WVE Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. WVE commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a Hold and WVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (DRUG: $50.10 vs. WVE: $6.83)
Brand notoriety: DRUG and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 59% vs. WVE: 82%
Market capitalization -- DRUG: $357.45M vs. WVE: $1.09B
DRUG [@Biotechnology] is valued at $357.45M. WVE’s [@Biotechnology] market capitalization is $1.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, DRUG is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 5 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).

  • DRUG’s TA Score: 5 bullish, 4 bearish.
  • WVE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than WVE.

Price Growth

DRUG (@Biotechnology) experienced а +10.28% price change this week, while WVE (@Biotechnology) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.10%, and the average quarterly price growth was +53.89%.

Reported Earning Dates

WVE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.09B) has a higher market cap than DRUG($357M). DRUG YTD gains are higher at: 39.089 vs. WVE (-44.786). DRUG has higher annual earnings (EBITDA): -8.94M vs. WVE (-134.84M). WVE has more cash in the bank: 208M vs. DRUG (51.4M). DRUG has less debt than WVE: DRUG (141K) vs WVE (21.7M). WVE has higher revenues than DRUG: WVE (93.9M) vs DRUG (0).
DRUGWVEDRUG / WVE
Capitalization357M1.09B33%
EBITDA-8.94M-134.84M7%
Gain YTD39.089-44.786-87%
P/E RatioN/AN/A-
Revenue093.9M-
Total Cash51.4M208M25%
Total Debt141K21.7M1%
FUNDAMENTALS RATINGS
WVE: Fundamental Ratings
WVE
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRUGWVE
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 20 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GVCAX12.090.04
+0.33%
Gabelli Value 25 AAA
JVAAX39.460.06
+0.15%
JPMorgan Value Advantage A
EFCNX24.56N/A
N/A
Emerald Insights Investor
JHGEX13.23N/A
N/A
JHancock Global Equity A
DDVIX14.35-0.01
-0.07%
Macquarie Value Inst

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with WVE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
-1.98%
WVE - DRUG
44%
Loosely correlated
-1.16%
PHMMF - DRUG
44%
Loosely correlated
N/A
IVA - DRUG
44%
Loosely correlated
-5.81%
TVGN - DRUG
32%
Poorly correlated
-4.24%
ATYR - DRUG
30%
Poorly correlated
-5.70%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-1.16%
PRQR - WVE
60%
Loosely correlated
N/A
KRRO - WVE
50%
Loosely correlated
+3.57%
OCUL - WVE
48%
Loosely correlated
+0.41%
DRUG - WVE
44%
Loosely correlated
-1.98%
KYMR - WVE
42%
Loosely correlated
-0.27%
More